The pharmacology of labetalol, an α- and β-adrenoceptor blocking agent
- 31 December 1978
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 9 (6) , 399-402
- https://doi.org/10.1016/0306-3623(78)90024-1
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- The effects of labetalol (AH 5158) on metabolism of 3H(−)-noradrenaline released from the cat spleen by nerve stimulationBiochemical Pharmacology, 1977
- Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patientsAmerican Heart Journal, 1977
- Mechanism of action of β-blockers in hypertensionBiochemical Pharmacology, 1977
- Pharmacological basis for antihypertensive effects of intravenous labetalol.Heart, 1977
- Assessment of alpha‐ and beta‐adrenoceptor blocking actions of labetalol.British Journal of Clinical Pharmacology, 1976
- Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension.BMJ, 1976
- THE EFFECTS OF ORAL AH 5158, A COMBINED α AND β-ADRENOCEPTOR ANTAGONIST, IN HEALTHY VOLUNTEERSPublished by Wiley ,1974
- Presynaptic regulation of catecholamine releaseBiochemical Pharmacology, 1974
- Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.Heart, 1974
- Adrenergic Stimulation of Renin Secretion in the Isolated Perfused Rat KidneyCirculation Research, 1973